News About: Pharm. Affairs
New insulin ‘Fiasp’ acts 2 twice faster than other insulin products
Fiasp(generic name: insulin aspart), a new regular insulin has raised expectation even before launching with its fast-acting feature.
Fiasp is an ultra-fast-acting insulin which effectively and safely control blood s...
Pharmacy society has a hard time when returning Chinese ‘Valsaltan’ ingredients
In a process of exchanging drugs containing Valsartan ingredients with carcinogenic factors, pharmacies are having trouble with patients over calculating patient-sharing expenses.
According to the pharmacy society, b...
Orphan drugs in development
Under the Orphan Drug Program enforced in 2013, total 18 products have been designated since the year.
According to the Ministry of Health and Welfare(MFDS), the government has introduced and enforced the Orphan Drug...
1,660 Korean people deliver signatures for ‘Opposition to Tylenol’ to MOHW
The pharmaceutical society and people delivered signatures to immediately suspend convenient stores to sell Tylenols and suggested the ‘National Task on Public Late-Night Pharmacy.’
The Society for the Future of Phar...
Convenient store association, “Selling emergency household medicines is not greed, but contribution”
While the pharmaceutical society and the convenient store field are opposing each other over emergency household medicines, the convenient store association once again refuted what the pharmaceutical association refut...
KPA, “We’ve never asked KRW 4.5 million for operating public late-night pharmacies”
The pharmaceutical association refuted that it was not true they requested KRW 4.5 million for public late-night pharmacy.
The Korea Pharmaceutical Association(KPA) announced in a refutation statement on the 4th that...
1 pharmacy for approximately 2,300 people in Korea
Among the 18 Korean cities and provinces, regional areas with the highest drug accessibility were reportedly Seoul, Daegu, Daejeon and Jeonbuk.
Yakup Shinmoon(www.yakup.com) analyzed population and the number of phar...
Upper for Lipiodol decided at KRW 190 thousand with obligation of stable supply
Lipiodol, which has recently been suspended in supply, has come to the final decision at the Health Insurance Policy Deliberation Committee after the drug price negotiation with the National Health Insurance Service(N...
Celltrion acquires Australian approval of trastuzumab biosimilar ‘Herzuma’
Celltrion recently announced they acquired sales approval of therapeutic antibody biosimilar for breast cancer and stomach cancer ‘Herzuma(generic name: trastuzumab)’ from the Australian Therapeutic Goods Administrati...
“15% of patients prescribed Chinese Valsartan did not receive notice for re-prescription”
It was criticized 15% of patients who took antihypertensives with Chinese Valsartan ingredients have not received any notice from their health care institute.
The Minjoo Party Rep. Sung-Gyu Meng mentioned this at the...
